Welcome to our dedicated page for U S PHYSICAL THERAPY /NV SEC filings (Ticker: USPH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on U S PHYSICAL THERAPY /NV's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into U S PHYSICAL THERAPY /NV's regulatory disclosures and financial reporting.
Williams Eric Joseph reported acquisition or exercise transactions in this Form 4 filing.
U S Physical Therapy reported that President and COO Eric Joseph Williams received a grant of 15,000 shares of common stock as restricted stock under the Amended and Restated 2003 Stock Incentive Plan. The award was recorded at a price of $0.0000 per share, indicating a non-cash equity grant.
The restrictions on these 15,000 shares lapse in fifteen equal quarterly installments of 936 shares on specified dates from May 20, 2026 through November 20, 2029, with a final 960 shares vesting on March 6, 2030, all subject to his continued employment. Following this grant, he directly holds 40,331 shares, including 31,322 restricted shares with a detailed vesting schedule extending from March 6, 2026 through March 6, 2030.
REEVE GRAHAM D. reported acquisition or exercise transactions in this Form 4 filing.
U.S. Physical Therapy COO Graham D. Reeve reported an equity award of 10,000 shares of common stock on February 23, 2026. The shares were granted as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan at a price of $0.00 per share.
The restrictions lapse in 15 quarterly installments of 624 shares beginning May 20, 2026, plus 640 shares vesting on March 6, 2030, subject to continued employment. Following the grant, Reeve directly holds 30,740 shares, including 23,348 restricted shares with scheduled vesting through 2030, and indirectly holds 1,808 shares through the Reeve Trust.
Binstein Richard reported acquisition or exercise transactions in this Form 4 filing.
U.S. Physical Therapy (USPH) executive Richard Binstein received an equity award rather than buying shares on the market. He was granted 10,000 shares of common stock as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan at a stated price of $0.0000 per share. These shares vest in 15 quarterly installments of 624 shares beginning on May 20, 2026 and on specified March 6, May 20, August 20, and November 20 dates through 2029, with a final 640-share installment vesting on March 6, 2030, in each case only if he remains employed by the company. Following this award, he directly owns 27,867 shares of common stock, including 22,624 restricted shares with multiple scheduled vesting dates between March 6, 2026 and March 6, 2030.
U.S. Physical Therapy, Inc. Chief Financial Officer Carey P. Hendrickson reported an acquisition of 10,000 shares of common stock as a restricted stock grant. The award carried a zero dollar price per share and increased his directly held total to 37,808 shares.
The 10,000-share grant vests in 15 equal quarterly installments of 624 shares from May 20, 2026 through November 20, 2029, plus 640 shares vesting on March 6, 2030, under the company’s Amended and Restated 2003 Stock Incentive Plan.
US Physical Therapy Inc received an updated Schedule 13G/A showing institutional ownership as of 12/31/2025. Kayne Anderson Rudnick Investment Management, LLC reports beneficial ownership of 1,212,494 US Physical Therapy Ord Shs, representing 8.0% of the class, with both sole and shared voting and dispositive powers.
Virtus Investment Advisers, LLC reports beneficial ownership of 731,069 shares, or 4.8%, all with shared voting and dispositive power. Virtus Equity Trust, on behalf of Virtus KAR Small-Cap Growth Fund, reports 667,088 shares, or 4.4%, with shared voting and dispositive power. The filers certify the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of US Physical Therapy.
U.S. Physical Therapy, Inc. reported two strategic moves. The company’s subsidiary partner, Metro Physical & Aquatic Therapy, entered a 10-year strategic alliance with NYU Langone Health to provide physical therapy services across Long Island and the New York metropolitan area.
On the same date, U.S. Physical Therapy announced it acquired a majority, 70% interest in an industrial injury prevention business for approximately $15.1 million, while the current owner retained 30%. The acquired business generates about $7.0 million in annual revenues, expanding U.S. Physical Therapy’s industrial injury prevention services portfolio.
Copeland Capital Management, LLC has filed a Schedule 13G reporting a passive ownership stake in U.S. Physical Therapy, Inc. common stock. The firm reports beneficial ownership of 786,114 shares, representing 5.17% of the outstanding common stock as of the event date.
Copeland Capital has sole voting power over 512,506 shares and shared voting power over 126,549 shares. It reports no sole dispositive power and shared dispositive power over all 786,114 shares. The securities are certified as being held in the ordinary course of business, not for the purpose of changing or influencing control of the company.
U.S. Physical Therapy, Inc. reported that it has acquired a 50% interest in a physical therapy management services company. This business exclusively manages a physical therapy practice with eight clinic locations, generating approximately $8.0 million in annual revenues and about 66,000 annual visits. The remaining 50% ownership is being retained by the current owners.
The transaction expands U.S. Physical Therapy’s presence in outpatient physical therapy and industrial injury prevention services by adding an established, revenue-generating group of clinics to its network.
U.S. Physical Therapy, Inc. (USPH) filed a Form 4 reporting an insider stock sale by its COO. On 11/24/2025, the reporting officer sold 743 shares of common stock in an open market transaction at a weighted average price of $71.01 per share, with individual trade prices ranging from $71.01 to $71.31.
After this transaction, the officer beneficially owns 20,740 shares directly and 1,808 shares indirectly through the Reeve Trust. The filing notes that 13,348 of these shares were granted as restricted stock under the company’s Amended and Restated 2003 Stock Incentive Plan, with portions scheduled to vest in installments between March 2026 and March 2029, contingent on continued employment.
U.S. Physical Therapy, Inc. (USPH) director reported a purchase of company stock. On 11/20/2025, the reporting person bought 4,000 shares of common stock at a price of $69 per share, coded as a purchase transaction on a Form 4 filing. After this trade, the director beneficially owns 24,786 shares directly.
This total includes 471 restricted shares that were granted under the company’s Amended and Restated 2003 Stock Incentive Plan. These restricted shares will fully vest on March 6, 2026, provided she continues to serve on the Board of Directors through that date.